ALNY · Alnylam Pharmaceuticals
Nasdaq-100 · Health Care
Five-year earnings research
20 dated report records. Open an edition for the reported earnings, expectations and measured price response.
Jun/2026
2026-07-30
EPS1.21Estimate1.44Surprise-15.97%
Read report analysis ↗Mar/2026
2026-04-30
EPS1.51Estimate0.91Surprise65.93%
Read report analysis ↗Dec/2025
2026-02-12
EPS—Estimate0.81Surprise—
Read report analysis ↗Sep/2025
2025-10-30
EPS1.84Estimate0.46Surprise300%
Read report analysis ↗Jun/2025
2025-07-31
EPS-0.52Estimate-0.58Surprise10.34%
Read report analysis ↗Mar/2025
2025-05-01
EPS-0.44Estimate1Surprise56%
Read report analysis ↗Dec/2024
2025-02-13
EPS-0.65Estimate-0.68Surprise4.41%
Read report analysis ↗Sep/2024
2024-10-31
EPS-0.87Estimate-1.02Surprise14.71%
Read report analysis ↗Jun/2024
2024-08-01
EPS-0.13Estimate-1.19Surprise89.08%
Read report analysis ↗Mar/2024
2024-05-02
EPS-0.52Estimate-1.26Surprise58.73%
Read report analysis ↗Dec/2023
2024-02-15
EPS-1.1Estimate-1.2Surprise8.33%
Read report analysis ↗Sep/2023
2023-11-02
EPS1.15Estimate-1.61Surprise171.43%
Read report analysis ↗Jun/2023
2023-08-03
EPS-2.21Estimate-1.72Surprise-28.49%
Read report analysis ↗Mar/2023
2023-05-04
EPS-1.4Estimate-1.97Surprise28.93%
Read report analysis ↗Dec/2022
2023-02-23
EPS-1.68Estimate-2.13Surprise21.13%
Read report analysis ↗Sep/2022
2022-10-27
EPS-3.32Estimate-1.86Surprise-78.49%
Read report analysis ↗Jun/2022
2022-07-28
EPS-2.29Estimate-1.62Surprise-41.36%
Read report analysis ↗Mar/2022
2022-04-28
EPS2Estimate-1.93Surprise-3.63%
Read report analysis ↗Dec/2021
2022-02-10
EPS-2.16Estimate-1.47Surprise-46.94%
Read report analysis ↗Sep/2021
2021-10-28
EPS-1.72Estimate-1.51Surprise-13.91%
Read report analysis ↗